CCM
LAB icon

Cupps Capital Management’s Standard BioTools LAB Stock Holding History

Cupps Capital Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,175
Closed -$133K – 204
2015
Q1 		$133K Sell
3,175
-1,225
-28% -$48.4K 0.01% 162
2014
Q4 		$148K Buy
+4,400
New +$125K 0.01% 177
2014
Q3 		– Sell
-103,261
Closed -$3.04M – 224
2014
Q2 		$3.04M Sell
103,261
-300,796
-74% -$9.64M 0.25% 110
2014
Q1 		$17.8M Sell
404,057
-17,768
-4% -$782K 1.36% 15
2013
Q4 		$16.1M Buy
421,825
+160,649
+62% +$4.73M 1.1% 26
2013
Q3 		$5.73M Buy
+261,176
New +$5.13M 0.37% 82

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cupps Capital Management's LAB Position: Q2 2015 in Review

Cupps Capital Management sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 3,175 shares — an estimated $133K sold.

Cupps Capital Management first reported a position in LAB in Q3 2013 and held it in 6 quarters. The position peaked at $17.8M in Q1 2014. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • Cupps Capital Management reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • Cupps Capital Management sold 3,175 Standard BioTools shares in Q2 2015, an estimated $133K.
  • Cupps Capital Management first reported a position in Standard BioTools in Q3 2013 and held it in 6 quarters.
  • Cupps Capital Management's Standard BioTools position peaked at $17.8M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on Cupps Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.